Enzon Pharmaceuticals Inc. (ENZN)
Sector: | Health Care |
Super Investor Stats: | |
Ownership count: | 0 |
Ownership rank: | -- |
% of all portfolios: | 0% |
History | Portfolio Manager | Activity | Share change | % change to portfolio ▼ | |
Q2  2016 | |||||
≡ | Carl Icahn - Icahn Capital Management | Sell 100.00% | 5,904,863 | 0.01 | |
Q1  2014 | |||||
≡ | Seth Klarman - Baupost Group | Sell 100.00% | 4,337,858 | 0.15 | |
Q4  2013 | |||||
≡ | Seth Klarman - Baupost Group | Reduce 43.60% | 3,353,595 | 0.12 | |
Q1  2013 | |||||
≡ | Seth Klarman - Baupost Group | Reduce 2.02% | 158,915 | 0.02 | |
Q4  2012 | |||||
≡ | Seth Klarman - Baupost Group | Reduce 12.78% | 1,150,510 | 0.17 | |
Q1  2011 | |||||
≡ | Seth Klarman - Baupost Group | Reduce 0.71% | 64,300 | 0.04 | |
Q4  2010 | |||||
≡ | Seth Klarman - Baupost Group | Reduce 12.69% | 1,317,520 | 0.95 | |
Q3  2010 | |||||
≡ | Seth Klarman - Baupost Group | Add 2.03% | 206,800 | 0.14 | |
Q2  2010 | |||||
≡ | Seth Klarman - Baupost Group | Add 10.57% | 972,798 | 0.78 | |
Q1  2010 | |||||
≡ | Seth Klarman - Baupost Group | Add 13.87% | 1,120,700 | 0.70 | |
Q4  2009 | |||||
≡ | Seth Klarman - Baupost Group | Add 290.19% | 6,011,018 | 4.67 | |
Q3  2009 | |||||
≡ | Seth Klarman - Baupost Group | Buy | 2,071,382 | 1.51 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.